ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 372155 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 372155; 2) Community: the network communities that were significantly associated with the response to NSC 372155; 3) Molecule: the relationships between components within communities and NSC 372155; 4) MDR: the compounds that were significantly associated with the NSC 372155.

NSC Compound Enrichment Correlation
NSC 705331 2-Propenamide, N-(1,1-dimethylethyl)-N-(phenylmethyl)- 3-(phenylsulfinyl)-, (2Z)- 0.0385613993886001 0.42504238
NSC 709483 Null 0.0385613993886001 0.27149089
NSC 710716 Null 0.0385613993886001 0.6770261
NSC 710895 3-[(1H-Indol-3-ylethyl)amino]-2-(3-isopropoxyphenyl)-2H-pyrido[4,3-e]-1,2,4,-thiadiazine 1,1-dioxide 0.0385613993886001 0.4328507
NSC 716951 Null 0.0385613993886001 0.25704187
NSC 719715 Null 0.0385613993886001 0.42006427
NSC 721049 7Z-Plakortide H 0.0385613993886001 0.27716732
NSC 722867 Null 0.0385613993886001 0.22070883
NSC 723732 8-{4-[6-(4-flurophenyl)-2-methyl-4-pyrimidinyloxy]butoxy}-7- methoxy-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a ][1,4]diazepin-5-one 0.0385613993886001 0.39123974
NSC 727087 16-[4-(2-diethylaminoethoxy)3-methoxy benzylidene]-17-oxo-5-androsten-3a-yl acetate 0.0385613993886001 0.18266027
Total:199  Current:173    [First] [Prev] [Next] [Last]